|
Inflection Point Acquisition Corp. Iii Rights 2025-
|
12/12
|
0,375
|
+0,27%
|
0,36
|
0,36 - 0,375
|
|
Inflection Point Acquisition Corp. Iii Units Cons Of
|
09/12
|
10,41
|
0,00%
|
0
|
---
|
|
Inflection Point Acquisition Corp. Iv
|
12/12
|
10,84
|
-0,55%
|
10,87
|
10,84 - 10,9699
|
|
Inflection Point Acquisition Corp. Iv Rights 2024-
|
12/12
|
0,83
|
+6,40%
|
0,925
|
0,8205 - 0,925
|
|
Inflection Point Acquisition Corp. Iv Units Cons Of
|
11/12
|
11,8
|
+2,79%
|
11,8
|
11,8 - 11,8
|
|
Inflection Point Acquisition Corp. V
|
12/12
|
10,25
|
-0,39%
|
10,26
|
10,25 - 10,26
|
|
Inflection Point Acquisition Corp. V Rights
|
11/12
|
0,938
|
-2,29%
|
0,938
|
0,938 - 0,9399
|
|
Inflection Point Acquisition Corp. V Units Cons Of
|
12/12
|
11,48
|
-18,00%
|
10,38
|
10,17 - 11,98
|
|
Infobird
|
12/12
|
0,978
|
+2,08%
|
0,9502
|
0,9502 - 1,0137
|
|
Information Services
|
12/12
|
6,05
|
+0,83%
|
6,03
|
6,01 - 6,175
|
|
Ingles Markets, Incorporated
|
12/12
|
70,45
|
-0,90%
|
70,83
|
70,32 - 71,65
|
|
Inhibikase Therapeutics
|
12/12
|
1,54
|
+0,98%
|
1,55
|
1,5 - 1,56
|
|
Inhibrx Biosciences
|
12/12
|
79,57
|
-3,21%
|
82,14
|
79,2 - 83,695
|
|
Inlif
|
12/12
|
0,5893
|
+0,17%
|
0,5811
|
0,571 - 0,5893
|
|
Inmed Pharmaceuticals
|
12/12
|
1,43
|
+2,88%
|
1,31
|
1,3503 - 1,48
|
|
Inmode Ltd
|
12/12
|
14,51
|
+0,42%
|
14,48
|
14,45 - 14,635
|
|
Inmune Bio
|
12/12
|
2,01
|
-6,07%
|
2,15
|
2,005 - 2,19
|
|
Innate Pharma
|
12/12
|
1,86
|
+0,54%
|
1,89
|
1,81 - 1,89
|
|
Inneova Holdings
|
12/12
|
0,65
|
-15,91%
|
0,7598
|
0,5904 - 0,7598
|
|
Inno Holdings
|
12/12
|
0,1411
|
+0,79%
|
0,14
|
0,1373 - 0,1454
|